|
시장보고서
상품코드
1517502
대사체학 : 기술과 세계 시장Metabolomics: Technologies and Global Markets |
||||||
세계 대사체학 시장 규모는 2024년 164억 달러에서 예측 기간 동안 연평균 13.1% 성장하여 2029년 말에는 302억 달러에 달할 것으로 예상됩니다.
분리 기술 부문은 2024년 83억 달러에서 연평균 13.1% 성장하여 2029년 말에는 154억 달러에 달할 것으로 예상됩니다. 검출 기술 부문은 2024년 80억 달러에서 연평균 13.0% 성장하여 2029년 말에는 148억 달러에 달할 것으로 예측됩니다.
세계 대사체학 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
- 시장 전망
- 조사 범위
- 시장 개요
제2장 시장 개요
- 개요
- 대사체학 개요
- 분리 기술
- 검출 기술
- 대사물과 그 응용
- 연구개발과 규제 승인
- 공급망 분석
제3장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 시장 과제
제4장 신기술과 개발
- 임상시험 분석
- 연구 유형별
- 상황별
- 성별
- 개입별
- 취득 특허
- 특허 분석
제5장 시장 세분화 분석
- 세분화 내역
- 대사체학 시장 : 제품별
- 세계 시장 분석과 예측
- 분리 기술
- 검출 기술
- 대사체학 시장 : 적응증별
- 세계 시장 분석과 예측
- 암
- 심혈관질환
- 신경학적 장애
- 선천성 대사이상
- 기타
- 대사체학 시장 : 용도별
- 세계 시장 분석과 예측
- 바이오마커 발견
- Drug Discovery
- 독성 시험
- 영양유전체학
- 기능유전체학
- 기타
- 대사체학 시장 : 지역별
- 세계
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
- 기업 점유율 분석
- 전략 분석
- M&A
- 벤처 캐피털 자금 조달
제7장 부록
- 조사 방법
- 약어
- 정보 출처
- 기업 개요
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- BRUKER
- DANAHER CORP.
- MERCK KGAA
- SHIMADZU CORP.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORP.
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
The global market for separation techniques for metabolomics technologies is expected to grow from $8.3 billion in 2024 and is projected to reach $15.4 billion by the end of 2029, at a CAGR of 13.1% during the forecast period of 2024 to 2029.
The global market for detection techniques for metabolomics technologies is expected to grow from $8.0 billion in 2024 and is projected to reach $14.8 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.
Report Scope
This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.
Report Includes
- 32 data tables and 39 additional tables
- An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
- Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
- A look at ESG trends
- Information on developments in R&D, clinical trials, emerging technologies, and economic trends
- Analysis of key companies' market shares, proprietary technologies, patents, and alliances
- Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Overview of Metabolomics
- Separation Techniques
- Detection Techniques
- Metabolites and Their Applications
- R&D and Regulatory Approval
- Supply Chain Analysis
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Technological Advancements
- Increasing Healthcare Expenditure
- Expanding Applications Across Industries
- Market Restraints
- High Cost of Instruments and Services
- Complexity of Data Analysis
- Standardization and Quality Control Challenges
- Limited Biomarker Validation and Clinical Utility
- Market Opportunities
- Precision Medicine and Personalized Healthcare
- Drug Discovery and Development
- Biomarker Discovery and Validation
- Nutritional Profiling and Functional Foods
- Environmental Monitoring and Toxicology
- Market Challenges
- Data Complexity and Interpretation
- Standardization and Quality Assurance
- Biomarker Validation and Clinical Translation
- Technological Limitations and Costs
- Regulatory and Ethical Considerations
Chapter 4 Emerging Technologies and Developments
- Introduction
- Clinical Trial Analysis
- By Study Type
- By Status
- By Gender
- By Interventions
- Granted Patents
- Introduction
- Patent Analysis
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Metabolomics Market, by Product
- Global Market Analysis and Forecast
- Separation Techniques
- Detection Techniques
- Metabolomics Market, by Indication
- Global Market Analysis and Forecast
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Other Diseases Indication
- Metabolomics Market, by Application
- Global Market Analysis and Forecast
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Others
- Geographic Breakdown
- Metabolomics Market, by Region
- Global
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Company Share Analysis
- Strategic Analysis
- Mergers and Acquisitions
- Venture Capital Funding
Chapter 7 Appendix
- Methodology
- Sources
- Acronyms
- Definitions/Taxonomy
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- BRUKER
- DANAHER CORP.
- MERCK KGAA
- SHIMADZU CORP.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORP.
